Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study

Citation
Afm. Stone et al., Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study, HEART, 86(5), 2001, pp. 506-509
Citations number
15
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
HEART
ISSN journal
13556037 → ACNP
Volume
86
Issue
5
Year of publication
2001
Pages
506 - 509
Database
ISI
SICI code
1355-6037(200111)86:5<506:IHDACA>2.0.ZU;2-E
Abstract
Objective To look for the presence of the more virulent strains of Helicoba cter pylori (H pylori) in men who developed ischaemic heart disease over a 10 year period and in controls. Design-The Caerphilly prospective heart disease study recruited 2512 men ag ed 45-59 years during 1979-83. Western blot analysis or enzyme linked immun osorbent assay (ELISA) was performed on serum taken from those who subseque ntly died of ischaemic heart disease, or developed non-fatal myocardial inf arction, to determine H pylori and Cag A status. Similar information was av ailable on age matched controls. Results-During the first decade of the study, 312 men died of ischaemic hea rt disease or developed non-fatal myocardial infarction. Serum was availabl e from 172 of these (55%). There was no evidence of an association between Cag A seropositivity and incident ischaemic heart disease or ischaemic hear t disease mortality, either before or after adjustment for potential confou nders (adjusted odds ratios 1.18 (95% confidence interval (CI) 0.76 to 1.85 ) and 1.13 (95% CI 0.61 to 2.07), respectively). Further, the odds ratios f or ischaemic heart disease incidence and ischaemic heart disease mortality by H pylori seropositivity did not appear to depend on the presence or abse nce of Cag A strains (p = 0.76 and 0.77, respectively). Conclusions-In this cohort of middle aged men, followed over a 10 year peri od, there is little evidence of an association between Cag A seropositivity and either incident ischaemic heart disease or ischaemic heart disease mor tality.